Results 221 to 230 of about 227,914 (337)

Multi-interface licensing of protein import into a phage nucleus. [PDF]

open access: yesNature
Kokontis C   +3 more
europepmc   +1 more source

Role of the Choline‐Binding Protein A in the Ability of Porcine Ligilactobacillus salivarius FFIG58 to Modulate TLR3‐Mediated Intestinal Antiviral Immunity

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
The choline‐binding protein A (CbpA) was shown to mediate adhesion of probiotic Ligilactobacillus salivarius strains to human intestinal epithelial cells (IECs). A knockout mutant lacking the CbpA protein derived from the immunomodulatory porcine strain L. salivarius FFIG58 was obtained. The CbpA is a key surface protein of L.
Yoshiya Imamura   +13 more
wiley   +1 more source

EcoRI and Pvull RFLPs in the endonexin ll/annexin V (ANX5) gene on chromosome four [PDF]

open access: bronze, 1991
Timothy M. Ritty   +3 more
openalex   +1 more source

Human Lysozyme Transgenic Maize Improves Colonic Inflammation by Inhibiting the cGAS/STING Signaling Pathway in DSS‐Induced Colitis Mice

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
Human lysozyme (HLZ) possesses the function of ameliorating intestinal inflammation. HLZ transgenic maize restored intestinal barrier function in colitis mice. HLZ‐feed inhibited the cGAS/STING signaling pathway by ameliorating DSS‐induced mitochondrial dysfunction.
Yinuo Yu   +5 more
wiley   +1 more source

Oral Delivery of R‐spondin1‐Loaded Small Extracellular Vesicles Activates WNT Signalling Pathway to Accelerate Intestinal Injury Repair and Reverse Ageing

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 1, January 2026.
Yang et al. demonstrated that HSPG mediate the loading of active R‐spondin1 protein onto the surface of small extracellular vesicles (evRSPO1). evRSPO1 induced WNT/β‐catenin activity in intestinal organoids and tissues, thereby regulating intestinal stem cells proliferation.
Lingyan Yang   +13 more
wiley   +1 more source

Structural Adaptability of IgA and IgM Supports Broad SARS‐CoV‐2 Variant Neutralization

open access: yesJournal of Medical Virology, Volume 98, Issue 1, January 2026.
ABSTRACT Neutralizing emerging SARS‐CoV‐2 variants requires antibodies effective not only against epitope mutations but also under variable antigenic presentations. We assessed the neutralization capacity of the same anti‐RBD monoclonal antibody (8A5) expressed as IgG, IgA, or IgM against 18 variants, identifying three neutralization classes: variants ...
Yalcin Pisil   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy